Rasagiline is a chemical compound used as an active pharmaceutical ingredient in medications for Parkinson's disease. It is employed as a monotherapy for early-stage symptoms or as an adjunct therapy in more advanced cases, and is administered orally.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing Rasagiline?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Rasagiline mesylate
pharmaceutical raw material
Scopine-2,2-dithienyl glycolate
pharmaceutical raw material
Tiotropium EP Impurity D
pharmaceutical raw material
Tiotropium bromide
pharmaceutical raw material
(S)-duloxetine hydrochloride
pharmaceutical raw material
(1R)-N-(prop-2-en-1-yl)-2,3-dihydro-1H-inden-1-amine
research compound
(1R,2S)-(+)-cis-1-Amino-2-indanol
pharmaceutical intermediate
2-Aminoindan hydrochloride
research compound
The international HS code for Rasagiline (CAS 136236-51-6) is 2921.49.
2921.49
2921 49 00
Classification per the EU customs inventory ECICS (2026-07 snapshot, HS 2022). National tariff lines and product form can affect the final classification.
(1R)-N-prop-2-ynyl-2,3-dihydro-1H-inden-1-amine
RUOKEQAAGRXIBM-GFCCVEGCSA-N
C#CCN[C@@H]1CCC2=CC=CC=C12
Sourcing Rasagiline?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.